Table 1 Baseline characteristics of patients who received chemotherapy
From: Subjective and objective assessment of oxaliplatin-induced peripheral neuropathy
XELOX+BV/XELOX | 40/18 |
|---|---|
Median age (range) | 65 (43–80) |
Male/female | 68.9/31.1 % |
ECOG PS 0/1 | 81.0/19.0 % |
Primary tumor colon/rectum | 53.4/46.6 % |
Oxaliplatin | 1751 mg/body (345–5903) |